Related references
Note: Only part of the references are listed.Cardiac Biomarker Responses to Dobutamine Stress Echocardiography in Healthy Volunteers and Patients with Coronary Artery Disease
Maithri Siriwardena et al.
CLINICAL CHEMISTRY (2012)
Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting The RED-CABG Randomized Controlled Trial
Mark F. Newman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure
Takayoshi Tsutamoto et al.
AMERICAN HEART JOURNAL (2010)
Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic cardiomyocytes
Fei Xiang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
Cardioprotection With Adenosine-Regulating Agent, GP531: Effects on No-Reflow, Infarct Size, and Blood Flow Following Ischemia/Reperfusion in the Rabbit
Sharon L. Hale et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Atenolol Is Inferior to Metoprolol in Improving Left Ventricular Function and Preventing Ventricular Remodeling in Dogs with Heart Failure
Valerio Zaca et al.
CARDIOLOGY (2009)
Acadesine, an adenosine-regulating agent with the potential for widespread indications
Brian G. Drew et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Cardiac troponin and outcome in acute heart failure
W. Frank Peacock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease - The PEACE trial
Torbjorn Omland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Adenosinergic cardioprotection: Multiple receptors, multiple pathways
Jason N. Peart et al.
PHARMACOLOGY & THERAPEUTICS (2007)
A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction
Hajime Funakoshi et al.
CIRCULATION (2007)
Direct comparison of B-Type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The valsartan heart failure (Val-HeFT) data
Serge Masson et al.
CLINICAL CHEMISTRY (2006)
Nitric oxide and mitochondrial biogenesis
Enzo Nisoli et al.
JOURNAL OF CELL SCIENCE (2006)
Post-reperfusion myocardial infarction - Long-term survival improvement using adenosine regulation with acadesine
Dennis T. Mangano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effects of the AT(1)-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure
G Suzuki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure
G Suzuki et al.
CIRCULATION (2002)
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure
MP Chandler et al.
CIRCULATION RESEARCH (2002)
Abnormal mitochondrial respiration in failed human myocardium
VG Sharov et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Effects of dopamine β-hydroxylase inhibition with nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure
HN Sabbah et al.
CIRCULATION (2000)
Adenosine and cardioprotection during ischaemia and reperfusion - an overview
HT Sommerschild et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2000)
Share Paper
